Mangiferin modulation of metabolism and metabolic syndrome.
Review
Overview
abstract
-
The recent emergence of a worldwide epidemic of metabolic disorders, such as obesity and diabetes, demands effective strategy to develop nutraceuticals or pharmaceuticals to halt this trend. Natural products have long been and continue to be an attractive source of nutritional and pharmacological therapeutics. One such natural product is mangiferin (MGF), the predominant constituent of extracts of the mango plant Mangifera indica L. Reports on biological and pharmacological effects of MGF increased exponentially in recent years. MGF has documented antioxidant and anti-inflammatory effects. Recent studies indicate that it modulates multiple biological processes involved in metabolism of carbohydrates and lipids. MGF has been shown to improve metabolic abnormalities and disorders in animal models and humans. This review focuses on the recently reported biological and pharmacological effects of MGF on metabolism and metabolic disorders. © 2016 BioFactors, 42(5):492-503, 2016.
publication date
published in
Research
keywords
-
Metabolic Syndrome
-
Plant Extracts
-
Xanthones
Identity
PubMed Central ID
Scopus Document Identifier
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
has global citation frequency
volume
issue